Latest Biotech News

Groundbreaking studies have deepened understanding of neurodegenerative diseases and brain physiology. New evidence confirms ongoing neurogenesis in adult human brains, identifying active neural...

Innovative approaches in stem cell science promise to transform regenerative therapies. Researchers engineered aligned mesenchymal stem cell sheets, significantly boosting protein secretion...

Spatial biology and multiomics integration are revolutionizing cancer research by elucidating tumor heterogeneity and microenvironmental interactions. Techniques mapping gene and protein...

Recent studies uncover critical genetic and molecular mechanisms across various cancers that have therapeutic implications. Investigations revealed microRNA links to peritoneal carcinomatosis in...

The biotechnology sector sees pivotal financial developments and strategic alliances. Catalio Capital Management closed a $400 million venture fund focused on innovative healthcare investments and...

Regulatory landscapes and leadership dynamics continue to evolve. The U.S. federal court ruled mass layoffs at the Department of Health and Human Services likely unlawful, suspending...

Saudi Arabia is aggressively implementing a national biotechnology strategy aimed at transforming the Kingdom into a global biotech hub. The plan focuses on creating an integrated ecosystem...

Regeneron Pharmaceuticals received accelerated FDA approval for Lynozyfic (linvoseltamab), a bispecific antibody targeting BCMA and CD3, for adults with relapsed and refractory multiple myeloma....

Google DeepMind unveiled AlphaGenome, a unified AI model predicting effects of DNA variants across molecular genomic properties with superior performance over existing tools. Meanwhile, Healx and...

Innovations in CAR T cell therapies are improving efficacy against solid tumors. Australian researchers used CRISPR to engineer CAR T cells with additional cancer-fighting protein activation at...

Researchers unveiled multiple breakthroughs improving diagnostic precision. A novel redox-sensitive PET tracer enables imaging of neuroinflammation in multiple sclerosis models. Machine learning...

Organon discontinued OG-6219, a non-hormonal endometriosis treatment, following phase 2 failure to improve pelvic pain. The drug was viewed as a key opportunity with a novel mechanism....

Bioversys AG partnered with Shionogi in a CHF529 million collaboration targeting multidrug-resistant lung infections using novel ansamycin antibiotics. Pusan National University engineered...

A federal judge blocked parts of the Trump administration’s HHS reorganization plan, ruling sweeping layoffs likely illegal, and temporarily halting implementation. Approximately 20,000 HHS jobs...

New molecular insights are advancing understanding of complex diseases. A study revealed that β-catenin supports cell survival during primitive streak formation in embryonic stem cells. In...

Recent developments in regulatory approvals are reshaping the oncology and diagnostic landscape. The FDA approved the Oncomine Dx Express assay as a companion diagnostic (CDx) for Dizal’s...

Artificial intelligence (AI) and machine learning (ML) continue to drive innovation across biotech and healthcare. Novel AI-powered platforms enhance drug discovery for spinal cord injury and...

Breakthroughs in cancer treatment are focusing on novel targets and modalities to overcome resistance and improve efficacy. Researchers revealed that targeting TP53-induced glycolysis and...

Innovative molecular and genomic biomarkers are transforming cancer diagnosis and treatment stratification. Studies have identified DNA methylation patterns as early cancer detection markers, and...

Recent research is deepening understanding of neurodegenerative diseases through advanced imaging and biomarker profiling. Quantitative MRI reveals microstructural putamen changes in Parkinson’s...